Advertisement

Ads Placeholder
Loading...

Zealand Pharma A/S

ZLDPFβ€’PNK
Healthcare
Biotechnology
$46.93
$2.46(5.53%)
U.S. Market opens in 4h 57m

ZLDPF News Today: Stay Updated with the Latest Zealand Pharma A/S News in Real Time

Find ZLDPF news now at Meyka AI. Stay informed with the latest Zealand Pharma A/S stocks updates, including price news, market analysis, and expert insights.

Sensex Jumps 500+ Points, Nifty 50 Crosses 23,900 on Banking Rally
πŸ“… in about 4 hours

Sensex Jumps 500+ Points, Nifty 50 Crosses 23,900 on Banking Rally

Indian stock markets opened on a strong note today, continuing their recent recovery trend. The mood on Dalal Street turned positive as buying interest returned in banking and financial stocks. The benchmark index Sensex surged more than 500 points in early trade. At the same time, the Nifty 50 crossed the key 23,900 level, showing…

Read more
Swiss Market Index Today, April 10: Oil Slide After Iran Truce in Focus
πŸ“… in 39 minutes

Swiss Market Index Today, April 10: Oil Slide After Iran Truce in Focus

Swiss Market Index today: investors watch if the relief rally can extend after an oil price slump linked to an Iran ceasefire report. Key levels, sectors, and tactics for April 10 in Switzerland.

Read more
BSE Sensex Today, April 09: Ceasefire, Oil Slide Fuel 4% Rebound
πŸ“… 18 hours ago

BSE Sensex Today, April 09: Ceasefire, Oil Slide Fuel 4% Rebound

BSE Sensex today jumped nearly 4% as a US-Iran ceasefire and Brent crude falls below $95 lifted risk appetite. Get sector moves, key Nifty levels, and strategy now.

Read more
Hang Seng Index Today, April 09: 3% Rally as Iran Truce Reopens Hormuz
πŸ“… 21 hours ago

Hang Seng Index Today, April 09: 3% Rally as Iran Truce Reopens Hormuz

Hang Seng Index jumps 3.1% to 25,893 as Iran truce lifts risk appetite and hopes for a Strait of Hormuz reopening. Tech leads with the Hang Seng Tech Index up 5.22%.

Read more
SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026
πŸ“… 21 hours ago

SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026

Citigroup initiates Buy coverage on Summit Therapeutics (SMMT) with initial analyst rating, citing scarcity value in competitive drug market.

Read more
SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026
πŸ“… 21 hours ago

SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026

Citigroup initiates Buy coverage on Summit Therapeutics (SMMT) with initial analyst rating, citing scarcity value in competitive drug market.

Read more
4506.T Stock Today: April 9 – Β₯116.5B Public Offering for R&D, Debt
πŸ“… 23 hours ago

4506.T Stock Today: April 9 – Β₯116.5B Public Offering for R&D, Debt

Sumitomo Pharma public opening: up to Β₯116.49B via 51.3M new shares plus 7.70M OA. Key dates Apr 20–30, dilution math, use of funds, and trading takeaways for Japan investors.

Read more
Pre-market Volume Spike: INL.AX Innlanz ASX 09 Apr 2026: A$0.009, watch volume
πŸ“… 1 day ago

Pre-market Volume Spike: INL.AX Innlanz ASX 09 Apr 2026: A$0.009, watch volume

Pre-market volume spike on INL.AX stock at A$0.009 on 09 Apr 2026; explore volume, valuation and Meyka AI forecast for ASX-listed Innlanz

Read more
CHF121.18 Novartis (NOVN.SW) SIX after-hours 08 Apr 2026: most active, analyst signals
πŸ“… 1 day ago

CHF121.18 Novartis (NOVN.SW) SIX after-hours 08 Apr 2026: most active, analyst signals

NOVN.SW stock trades CHF121.18 after hours on SIX 08 Apr 2026; volume 3.32M. Meyka AI analysis and forecasts

Read more

ZLDPF News FAQ